Clinical Trial: A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Infliximab Induction Therapy Followed by Multiple Regimens of Maintenance InfliximabT

Brief Summary: The purpose of the study is to evaluate the safety and effectiveness of scheduled and as needed treatment of psoriasis with infliximab. Infliximab (Remicade) targets specific proteins in the body's immune system to help control the development of inflammation to help reduce painful disease.